Devin J. Shaw
Director of Finance/CFO at IMMUNE PHARMACEUTICALS, INC.
Devin J. Shaw active positions
Companies | Position | Start | End |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Director of Finance/CFO | 12/04/2021 | - |
Career history of Devin J. Shaw
Statistics
International
United States | 2 |
Operational
Director of Finance/CFO | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Stock Market
- Insiders
- Devin J. Shaw
- Experience